secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUCELL CORP /DE/ (ICCC)
CIK:        0000811641
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001213900-25-057768
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmuCell CEO Michael Brigham plans retirement by early 2026; board launches succession search
--------------------------------------------------------------------------------

- President/CEO Michael Brigham (65) intends to retire from full-time work by early 2026; board has started successor search.
- Brigham's prior CFO responsibilities transferred to recently hired CFO Timothy C. Fiori.
- Goal to identify new CEO candidate by around year-end 2025; Brigham will stay until transition complete.
- Brigham to remain on board through term ending June 2026 and beyond, subject to stockholder vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811641/000121390025057768/0001213900-25-057768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811641/000121390025057768/ea0247006-8k_immucell.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-057768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer